Eiger BioPharmaceuticals, Inc.
USD1.73
+0.00 (+0.00%)
CEO
David Apelian
IPO Date
2014-01-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.90
Prev. Close
$1.73
Day Low
$1.73
Day High
$1.90
52W Low
$1.73
52W High
$1.90
Market Cap
$0.00B
Volume
0.14M
| -0.5 |
| 31 Dec 2021 | FY | 87.3% | -279.3% | -46.8% | -26.8% | 0.45 | 3.46 | -5.2 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -68.4% | -45.2% | 0.34 | 8.29 | -5.3 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -124.4% | -66.8% | 0.57 | 5.92 | -4.8 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -78.7% | -51.1% | 0.38 | 10.16 | -2.7 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -188.5% | -99.0% | 0.67 | 5.85 | -2.9 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -115.6% | -77.5% | 0.36 | 11.44 | -1.5 |
| -0.2 |
| 30 Jun 2023 | Q2 | 102.7% | -445.7% | -135.3% | -28.6% | 2.66 | 4.22 | -0.4 |
| 31 Mar 2023 | Q1 | 92.5% | -553.3% | -64.7% | -23.0% | 1.15 | 4.04 | -0.4 |
| 31 Dec 2022 | Q4 | 79.2% | -932.4% | -45.4% | -20.9% | 0.73 | 4.68 | -0.5 |
| 30 Sept 2022 | Q3 | 64.1% | -673.7% | -34.6% | -18.9% | 0.51 | 5.45 | -3.1 |
| 30 Jun 2022 | Q2 | 91.2% | -534.9% | -21.3% | -13.4% | 0.38 | 7.22 | -3.1 |
| 31 Mar 2022 | Q1 | 88.2% | -847.1% | -23.3% | -14.8% | 0.34 | 4.02 | -3.2 |
| 31 Dec 2021 | Q4 | 91.0% | -647.9% | -30.1% | -17.2% | 0.45 | 3.46 | -2.0 |
| 30 Sept 2021 | Q3 | 83.2% | -731.3% | -24.8% | -15.8% | 0.36 | 4.50 | -2.6 |